PDLI
PDL BioPharma, Inc.
NasdaqGS
People also watch:AFFXMYGNINCYVRTXIMCL
3.520.01 (0.28%)

After hours: 3.520.00 (0.00%) as of 4:44 PM EDT

Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close3.51
Open3.49
Bid3.37 x 1000
Ask3.65 x 4900
52wk Range2.58 - 6.11
Day's Range3.48 - 3.56
Volume572,420
Avg Vol (3m)1,327,768
As of 4:00 PM EDT. Market closed.
  • The 3 Most Dangerous High-Yield Dividend Stocks
    Motley Fool4 days ago

    The 3 Most Dangerous High-Yield Dividend Stocks

    The 5%+ dividend stocks could yield more headaches and heartaches than profits.

  • PDL BioPharma, Inc. – Value Analysis (NASDAQ:PDLI) : July 18, 2016
    Capital Cube5 days ago

    PDL BioPharma, Inc. – Value Analysis (NASDAQ:PDLI) : July 18, 2016

    Click here to see latest analysisCapitalcube gives PDL BioPharma, Inc. a score of 68.Our analysis is based on comparing PDL BioPharma, Inc. with the following peers – Compugen Ltd., Nektar Therapeutics, BioTime, Inc., Mylan N.V., Enzon Pharmaceuticals, Inc., Eli Lilly and Company, Amgen Inc. and Sangamo BioSciences, Inc. (CGEN-US, NKTR-US, BTX-US, MYL-US, ENZN-US, LLY-US, AMGN-US […] (Read more...) The post PDL BioPharma, Inc. – Value Analysis (NASDAQ:PDLI) : July 18, 2016 appeared first on CapitalCube.